BOT is now approaching a $250 million market and has added more than $100 million of market cap following their successful phase 1a results.
IHL has a MC of $25 million and about to commence four independent clinical trials. There’s no more capital required so the only way to be part of the story is to buy in the market.
- Forums
- ASX - By Stock
- IHL
- Ann: Update on Placement/Cleansing Prospectus
Ann: Update on Placement/Cleansing Prospectus, page-16
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)